Wanniarachchi, H.I.; Schuetze, R.; Deng, Y.; Hamal, K.B.; Pavlich, C.I.; Tankoano, P.E.O.; Tamminga, C.; Hammers, H.; Kapur, P.; Bueno, L.M.A.;
et al. Evaluating Therapeutic Efficacy of the Vascular Disrupting Agent OXi8007 Against Kidney Cancer in Mice. Cancers 2025, 17, 771.
https://doi.org/10.3390/cancers17050771
AMA Style
Wanniarachchi HI, Schuetze R, Deng Y, Hamal KB, Pavlich CI, Tankoano PEO, Tamminga C, Hammers H, Kapur P, Bueno LMA,
et al. Evaluating Therapeutic Efficacy of the Vascular Disrupting Agent OXi8007 Against Kidney Cancer in Mice. Cancers. 2025; 17(5):771.
https://doi.org/10.3390/cancers17050771
Chicago/Turabian Style
Wanniarachchi, Hashini I., Regan Schuetze, Yuling Deng, Khagendra B. Hamal, Cyprian I. Pavlich, Pouguiniseli E. O. Tankoano, Caleb Tamminga, Hans Hammers, Payal Kapur, Lorena M. A. Bueno,
and et al. 2025. "Evaluating Therapeutic Efficacy of the Vascular Disrupting Agent OXi8007 Against Kidney Cancer in Mice" Cancers 17, no. 5: 771.
https://doi.org/10.3390/cancers17050771
APA Style
Wanniarachchi, H. I., Schuetze, R., Deng, Y., Hamal, K. B., Pavlich, C. I., Tankoano, P. E. O., Tamminga, C., Hammers, H., Kapur, P., Bueno, L. M. A., Rayas, R., Wang, T., Liu, L., Trawick, M. L., Pinney, K. G., & Mason, R. P.
(2025). Evaluating Therapeutic Efficacy of the Vascular Disrupting Agent OXi8007 Against Kidney Cancer in Mice. Cancers, 17(5), 771.
https://doi.org/10.3390/cancers17050771
